DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Febrile Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Febrile Neutropenia (153)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 153   Next >>

Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-23

Patient: female

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-21

Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-17
    End date: 2012-07-20

Dasatinib
    Dosage: 40 milligram daily;
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-29

Mercaptopurine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-13
    End date: 2012-07-21

Other drugs received by patient: Zofran; Miralax



Possible Cytarabine side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-22

Patient: 54 year old female

Reactions: Osteomyelitis, Febrile Neutropenia, Osteonecrosis, Bacterial Disease Carrier, Face Oedema, Osteonecrosis of JAW, Endocarditis Enterococcal, Bone Marrow Failure, Candidiasis, Purulent Discharge, Pain in JAW

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg/m2, unk
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: 3 g/m2 every 12 hours for 4 days

Daunorubicin HCL
    Dosage: 45 mg/m2, unk
    Indication: Acute Myeloid Leukaemia

Idarubicin HCL
    Dosage: 12 mg/m2, unk
    Indication: Acute Myeloid Leukaemia



Possible Cytarabine side effects in 14 year old male

Reported by a physician from Norway on 2012-08-21

Patient: 14 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Mucosal Inflammation, Listless, Fatigue, Febrile Neutropenia, Sinusitis, Decreased Appetite

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Celecoxib
    Dosage: 400 mg, 2x/day
    Indication: Medulloblastoma

Cytarabine
    Dosage: 50 mg, cyclic, every other month

Cytarabine
    Dosage: 50 mg, cyclic, every other week then monthly
    Indication: Medulloblastoma

Etoposide
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Medulloblastoma

Thalidomide
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Medulloblastoma

Other drugs received by patient: Prednisolone Succinate



Possible Cytarabine side effects in male

Reported by a consumer/non-health professional from Netherlands on 2012-08-20

Patient: male, weighing 76.0 kg (167.2 pounds)

Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Pericarditis, Cerebral Artery Embolism, Respiratory Failure, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 19.6 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-01

Cytarabine
    Dosage: 391 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-03

Idarubicin HCL
    Dosage: 23.5 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-03-30



Possible Cytarabine side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient: 61 year old female

Reactions: Rash Pustular, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Diffuse Large B-Cell Lymphoma Recurrent, Rash, Sensorimotor Disorder, Skin Plaque, Mood Altered, Epidermal Necrosis, Oedema, Blister

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Methotrexate
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Etoposide; Melphalan Hydrochloride; Carmustine



Possible Cytarabine side effects in male

Reported by a consumer/non-health professional from Belgium on 2012-08-10

Patient: male, weighing 76.0 kg (167.2 pounds)

Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Pericarditis, Cerebral Artery Embolism, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 19.6 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-01

Cytarabine
    Dosage: 391 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-03

Floxacillin Sodium

Idarubicin HCL
    Dosage: 23.5 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-03-30



Possible Cytarabine side effects in 45 year old male

Reported by a physician from United States on 2012-08-08

Patient: 45 year old male

Reactions: Electrocardiogram QT Prolonged, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acyclovir
    Indication: Prophylaxis

Cytarabine
    Dosage: 200 mg/m2, cyclic, (total dose 43.02 mg)
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-12-24

Cytarabine
    Dosage: 200 mg/m2, cyclic, (total dose 44.46 g)
    Start date: 2012-05-30

Daunorubicin HCL
    Dosage: 60 mg/m2, cyclic, (total 5 courses of therapy)
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-12-24

Fluconazole
    Indication: Prophylaxis

Piperacillin
    Indication: Prophylaxis

Sprycel
    Dosage: 50 mg, cyclic, (total dose 1800 mg)
    Start date: 2012-03-19

Sprycel
    Dosage: 100 mg, cyclic, (total dose 2100 mg)
    Start date: 2012-05-30

Sprycel
    Dosage: 100 mg, cyclic
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-12-24



Possible Cytarabine side effects in male

Reported by a physician from Belgium on 2012-08-06

Patient: male, weighing 76.0 kg (167.2 pounds)

Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Cerebral Artery Embolism, Pericarditis, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 19.6 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-01

Cytarabine
    Dosage: 391 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-03

Floxacillin Sodium

Idarubicin HCL
    Dosage: 23.5 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-03-30



Possible Cytarabine side effects in 33 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient: 33 year old male, weighing 93.0 kg (204.6 pounds)

Reactions: Lactobacillus Infection, Blood PH Increased, Tachycardia, Blood PH Decreased, Device Related Infection, Scleral Haemorrhage, Bacterial Sepsis, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Blood Bicarbonate Increased, Acute Respiratory Failure, Renal Failure Acute, Febrile Neutropenia, Haemodialysis, Alopecia, Treatment Failure, Base Excess Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
(Investigational Drug)
    Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-17
    End date: 2012-04-23

(Investigational Drug)
    Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-02
    End date: 2012-04-08

Amphotericin B
    Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
    Indication: Fungal Infection
    Start date: 2012-05-06
    End date: 2012-05-08

Amphotericin B
    Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
    Indication: Infection Prophylaxis
    Start date: 2012-05-06
    End date: 2012-05-08

Aztreonam
    Dosage: see image
    Indication: Bacterial Infection
    Start date: 2012-05-06
    End date: 2012-05-07

Aztreonam
    Dosage: see image
    Indication: Bacterial Infection
    Start date: 2012-04-09
    End date: 2012-04-10

Caspofungin Acetate
    Dosage: see image
    Indication: Infection
    Start date: 2012-04-09

Caspofungin Acetate
    Dosage: see image
    Indication: Infection
    Start date: 2012-04-08
    End date: 2012-04-08

Caspofungin Acetate
    Dosage: see image
    Indication: Infection
    Start date: 2012-05-20
    End date: 2012-05-22

Cefepime
    Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-03-29
    End date: 2012-04-10

Cefepime
    Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-06-02
    End date: 2012-06-05

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-14
    End date: 2012-04-20

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-30
    End date: 2012-04-05

Daunorubicin HCL
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-30
    End date: 2012-04-01

Daunorubicin HCL
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-14
    End date: 2012-04-16

Imipenem and Cilastatin
    Dosage: 1000 mg, q8 hours intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-05-07
    End date: 2012-05-28

Penicillin G
    Dosage: 24000000 u, q24 hrs intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-05-04
    End date: 2012-05-09

Vancomycin
    Indication: Product Used FOR Unknown Indication

Voriconazole
    Dosage: 522 mg, q12 hours, intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-08
    End date: 2012-05-08

Other drugs received by patient: Ondansetron; Seroquel; Percocet; Nystatin; Zyloprim; Acetaminophen; Calcium Carbonate; Lorazepam; Xanax; Allopurinol; Calcium Gluconate; Ibuprofen; Hydroxyzine Pamoate; Celexa



Possible Cytarabine side effects in 50 year old female

Reported by a individual with unspecified qualification from Canada on 2012-07-26

Patient: 50 year old female

Reactions: Haemoptysis, Haemorrhage, Refractoriness To Platelet Transfusion, Petechiae, Pancytopenia, Febrile Neutropenia, Alveolitis Allergic, Panniculitis, Colitis, Laryngospasm, Klebsiella Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, on days 1-7
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2, on days 1-5
    Indication: Acute Myeloid Leukaemia

Idarubicin Hydrochloride
    Dosage: 12 mg/m2, on days 1-3
    Indication: Acute Myeloid Leukaemia

Mitoxantrone Hydrochloride
    Dosage: 10 mg/m2, on days 1-5
    Indication: Acute Myeloid Leukaemia



Possible Cytarabine side effects in female

Reported by a physician from Sweden on 2012-07-26

Patient: female, weighing 68.5 kg (150.7 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 100mgm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2011-05-19

Cytarabine
    Dosage: 4gm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2011-05-20

Dexamethasone
    Dosage: 40mg every 3 weeks
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2011-05-19

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2011-05-19



Possible Cytarabine side effects in 59 year old female

Reported by a physician from United States on 2012-07-18

Patient: 59 year old female

Reactions: Respiratory Failure, Platelet Count Decreased, Febrile Neutropenia, Upper Gastrointestinal Haemorrhage, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-11

Cytarabine
    Dosage: 1920 mg, cyclic
    Start date: 2012-05-16
    End date: 2012-05-16

Sprycel
    Dosage: 600 mg, cyclic
    Administration route: Oral
    Start date: 2012-05-16
    End date: 2012-05-26

Sprycel
    Dosage: unk
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-11



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-17

Patient: 50 year old female

Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis, Laryngospasm

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, on days 1-7
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2, on days 1-5
    Indication: Acute Myeloid Leukaemia

Idarubicin Hydrochloride
    Dosage: 12 mg/m2, on days 1-3
    Indication: Acute Myeloid Leukaemia

Mitoxantrone Hydrochloride
    Dosage: 10 mg/m2, on days 1-5
    Indication: Acute Myeloid Leukaemia



Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient:

Reactions: Bacteraemia, Febrile Neutropenia, Haematotoxicity

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Cytarabine
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Mabthera
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Methotrexate
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Vincristine
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive



Possible Cytarabine side effects in

Reported by a individual with unspecified qualification from Croatia (Local Name: Hrvatska) on 2012-07-13

Patient:

Reactions: Mucosal Inflammation, Multi-Organ Failure, Tumour Lysis Syndrome, Febrile Neutropenia, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Burkitt's Lymphoma

Doxorubicin Hydrochloride
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Mabthera
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Prophylaxis

Prednisone
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma



Possible Cytarabine side effects in female

Reported by a individual with unspecified qualification from Netherlands on 2012-07-13

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Febrile Neutropenia, Pyrexia, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: last dose prior to sae 05/jun/2012
    Start date: 2012-06-05

Cisplatin
    Dosage: last dose prior to sae 05/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-04

Cytarabine
    Dosage: last dose prior to sae 06/jun/2012
    Start date: 2012-06-06

Cytarabine
    Dosage: last dose prior to sae 05/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-05

Dexamethasone
    Dosage: last dose prior to sae 07/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-04

Dexamethasone
    Dosage: last dose prior to sae 08/jun/2012
    Start date: 2012-06-05

Mabthera
    Dosage: last dose prior to sae 08/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-08

Mabthera
    Dosage: last dose prior to sae 09/jun/2012
    Start date: 2012-06-09

Other drugs received by patient: Augmentin '125'; Ciprofloxacin HCL; Nexium; Fungizone; Keppra; Keppra; Valganciclovir; Allopurinol



Possible Cytarabine side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 300 mg/m2

Cyclophosphamide
    Dosage: 250 mg/m2, bid for six doses
    Indication: non-Hodgkin's Lymphoma

Cytarabine
    Dosage: 100 mg/m2, daily x 5 days
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Dosage: 30 mg/m2, single
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Dosage: 60 mg/m2, single

Hydrocortisone Acetate
    Dosage: given with methotrexate
    Indication: non-Hodgkin's Lymphoma

Hydrocortisone Acetate
    Dosage: given with cytarabine

Methotrexate
    Dosage: 3000 mg/m2, single

Methotrexate
    Dosage: given with hydrocortisone twice x 2
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Dosage: 1500 mg/m2, single

Prednisolone
    Dosage: 60 mg/m2, daily for 5 days then tapered over 3 days
    Indication: non-Hodgkin's Lymphoma

Prednisolone
    Dosage: 60 mg/m2, daily for 7 days

Rituximab
    Dosage: 1875 mg/m2, every 2-4 weeks for 5 total doses
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: 2 mg/m2, single

Vincristine
    Dosage: 1 mg/m2, single
    Indication: non-Hodgkin's Lymphoma



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06

Patient: 50 year old female

Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2 on d1-7; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Idarubicin HCL
    Dosage: 12 mg/m2 on d1-3; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Mitoxantrone
    Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Vercyte



Possible Cytarabine side effects in 77 year old male

Reported by a consumer/non-health professional from Japan on 2012-07-06

Patient: 77 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Sepsis, Circulatory Collapse, Febrile Neutropenia, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-05-28
    End date: 2010-08-19

Methotrexate
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-05-28
    End date: 2010-08-19

Oncovin
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-08-23
    End date: 2010-08-30

Pinorubin
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-08-23
    End date: 2010-08-25

Prednisolone
    Dosage: 10mg/day 28may10-19aug10,23aug10-31aug10
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-05-28
    End date: 2010-08-31

Sprycel
    Dosage: 70mg 2/1d 28jun-05jul 50mg 1/1d 06jul-22aug10 reduced 140mg to 50mg
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-06-28
    End date: 2010-08-22

Other drugs received by patient: Lasix; Sodium Bicarbonate; Neutrogin; Diamox; Famotidine; Pursennid



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06

Patient: 50 year old female

Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Petechiae, Pancytopenia, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Death, Panniculitis, Colitis, Thrombocytopenia, Laryngospasm, Klebsiella Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2 on d1-7; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Idarubicin HCL
    Dosage: 12 mg/m2 on d1-3; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Immune Globulin NOS
    Indication: Pancytopenia

Mitoxantrone
    Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Vercyte



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06

Patient: 50 year old female

Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Petechiae, Febrile Neutropenia, Pancytopenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2 on d1-7; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Idarubicin HCL
    Dosage: 12 mg/m2 on d1-3; induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Mitoxantrone
    Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Vercyte



Possible Cytarabine side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from Singapore on 2012-07-05

Patient: 65 year old female

Reactions: Pneumonia Klebsiella, Diarrhoea, Sepsis, Chills, Febrile Neutropenia, Anal Abscess, Toxic Skin Eruption

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine

Other drugs received by patient: Idarubicin HCL



Possible Cytarabine side effects in female

Reported by a individual with unspecified qualification from Netherlands on 2012-07-05

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Febrile Neutropenia, Pyrexia, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: last dose prior to sae 05/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-04

Cisplatin
    Dosage: last dose prior to sae 05/jun/2012
    Start date: 2012-06-05

Cytarabine
    Dosage: last dose prior to sae 05/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-05

Cytarabine
    Dosage: last dose prior to sae 06/jun/2012
    Start date: 2012-06-06

Dexamethasone
    Dosage: last dose prior to sae 08/jun/2012
    Start date: 2012-06-05

Dexamethasone
    Dosage: last dose prior to sae 07/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-04

Mabthera
    Dosage: last dose prior to sae 08/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-08

Mabthera
    Dosage: last dose prior to sae 09/jun/2012
    Start date: 2012-06-09

Other drugs received by patient: Ciprofloxacin HCL; Augmentin '125'; Valganciclovir; Keppra; Fungizone; Nexium; Allopurinol



Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from China on 2012-07-02

Patient:

Reactions: Thrombocytosis, NO Therapeutic Response, Febrile Neutropenia, Bone Marrow Failure, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Aclarubicin (Aclarubicin) Unspecified
    Dosage: 10 mg, in 1 cyclical
    Indication: Myeloid Leukaemia

Aclarubicin (Aclarubicin) Unspecified
    Dosage: 10 mg, in 1 cyclical
    Indication: Myelodysplastic Syndrome

Cytarabine
    Dosage: 10 mg/m2, in 1 cyclical
    Indication: Myeloid Leukaemia

Cytarabine
    Dosage: 10 mg/m2, in 1 cyclical
    Indication: Myelodysplastic Syndrome

Decitabine
    Dosage: 15 mg/m2, in 1 cyclical, intravenous
    Indication: Myeloid Leukaemia

Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
    Indication: Myelodysplastic Syndrome

Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
    Indication: Myeloid Leukaemia

Other drugs received by patient: Hydroxyurea; Homoharringtonine (Homoharringtonine)



Possible Cytarabine side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-29

Patient: 50 year old female

Reactions: Mouth Haemorrhage, Haemoptysis, Acute Myeloid Leukaemia, Petechiae, Febrile Neutropenia, Pancytopenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Laryngospasm, Klebsiella Sepsis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, on days 1 to 7
    Indication: Acute Myeloid Leukaemia

Etoposide
    Dosage: 100 mg/m2 on days 1-5
    Indication: Acute Myeloid Leukaemia

Idarubicin HCL
    Dosage: 12 mg/m2, on days 1 and 3
    Indication: Acute Myeloid Leukaemia

Mitoxantrone
    Dosage: 10 mg/m2, unk
    Indication: Acute Myeloid Leukaemia



Possible Cytarabine side effects in male

Reported by a physician from Belgium on 2012-06-28

Patient: male, weighing 76.0 kg (167.2 pounds)

Reactions: Hepatic Function Abnormal, Splenic Embolism, Febrile Neutropenia, Encephalopathy, Pneumonia Cytomegaloviral, Mucosal Inflammation, Cerebral Artery Embolism, Pericarditis, Respiratory Failure, Ventricular Tachycardia, Sepsis, Acute Respiratory Distress Syndrome, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 391 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-03

Evoltra
    Dosage: 19.6 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-01

Floxacillin Sodium

Idarubicin HCL
    Dosage: 23.5 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-03-30



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28

Patient: male, weighing 74.8 kg (164.6 pounds)

Reactions: Enterovesical Fistula, Oedema Peripheral, Febrile Neutropenia, Abscess

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 57.3 mg, qd, for 5 days
    Start date: 2012-03-16
    End date: 2012-03-20

Clolar
    Dosage: 46 mg, qd for consolidation treatment
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-28

Cytarabine
    Dosage: 3820 mg, qd for induction treatment, for 5 days
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-16
    End date: 2012-03-20

Cytarabine
    Dosage: 3600 mg, qd, for 4 days
    Start date: 2012-04-28
    End date: 2012-05-01

Neupogen
    Dosage: 300 mcg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-15
    End date: 2012-04-04

Neupogen
    Dosage: 300 mcg, qd
    Start date: 2012-04-28
    End date: 2012-05-01

Other drugs received by patient: Nicotine; Docusate; Lorazepam; Hydrocodone Bitartrate and Acetaminophen; Ondansetron (Zofran); Omeprazole; Lorazepam; Zolpidem; Acyclovir; Senna-Mint WAF; Oxycodone HCL; Levaquin; Voriconazole



Possible Cytarabine side effects in 38 year old female

Reported by a physician from United States on 2012-06-25

Patient: 38 year old female

Reactions: White Blood Cell Count Decreased, Anaemia, Febrile Neutropenia, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 5640 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Leucovorin Calcium
    Dosage: 125 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Methotrexate Sodium
    Dosage: 1880 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Methylprednisolone
    Dosage: 300 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Sprycel
    Dosage: 980 mg, unk
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13



Possible Cytarabine side effects in female

Reported by a individual with unspecified qualification from Netherlands on 2012-06-22

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Febrile Neutropenia, Pyrexia, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: last dose prior to sae 05/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-04

Cisplatin
    Dosage: last dose prior to sae 05/jun/2012
    Start date: 2012-06-05

Cytarabine
    Dosage: last dose prior to sae 06/jun/2012
    Start date: 2012-06-06

Cytarabine
    Dosage: last dose prior to sae 05/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-05

Dexamethasone
    Dosage: last dose prior to sae 08/jun/2012
    Start date: 2012-06-05

Dexamethasone
    Dosage: last dose prior to sae 07/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-04

Mabthera
    Dosage: last dose prior to sae 08/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-08

Mabthera
    Dosage: last dose prior to sae 09/jun/2012
    Start date: 2012-06-09

Other drugs received by patient: Keppra; Valganciclovir; Fungizone; Ciprofloxacin HCL; Depakene; Augmentin '125'; Nexium; Allopurinol



Possible Cytarabine side effects in female

Reported by a individual with unspecified qualification from United States on 2012-06-22

Patient: female, weighing 65.2 kg (143.4 pounds)

Reactions: Pneumonia, Febrile Neutropenia, Bone Marrow Failure, Escherichia Bacteraemia, Aspergillus Test Positive, Hydropneumothorax

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 40800 mg

Elspar
    Dosage: 20000 mg



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014